Show simple item record

AuthorImamovic, Denira
AuthorVranic, Semir
Available date2019-04-04T08:19:05Z
Publication Date2017-12-01
Publication NameAnnals of translational medicine
Identifierhttp://dx.doi.org/10.21037/atm.2017.09.32
CitationImamovic D, Vranic S. Novel regulators of PD-L1 expression in cancer: CMTM6 and CMTM4—a new avenue to enhance the therapeutic benefits of immune checkpoint inhibitors. Ann Transl Med 2017;5(23):467. doi: 10.21037/atm.2017.09.32
ISSN2305-5839
URIhttp://hdl.handle.net/10576/11469
AbstractCMTM6 and CMTM4-a new avenue to enhance the therapeutic benefits of immune checkpoint inhibitors
Languageen
PublisherAME Publishing Company
Subjecttargeted therapy
immune checkpoint inhibitors
PD-L1
cancer
TitleNovel regulators of PD-L1 expression in cancer: CMTM6 and CMTM4-a new avenue to enhance the therapeutic benefits of immune checkpoint inhibitors.
TypeArticle
Issue Number23
Volume Number5
dc.accessType Open Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record